1. British Committee for Standards in HaematologyGeneral Haematology Task Force. Guidelines forthe investigation and management of idiopathicthrombocytopenic purpura in adults, children andin pregnancy. Br J Haematol. 2003; 120:574.

2. Cines DB, Blanchette VS. Immunethrombocytopenic purpura. N Engl J Med. 2002;346:99

3. Frederiksen H, Schmidt K. The incidence ofidiopathic thrombocytopenic purpura in adultsincreases with age. Blood. 1999; 94:909.

4. Zeller B, Rajantie J, Hedlund-Treutiger I,Tedgard U, Wesenberg F, Jonsson OG, et al.Childhood idiopathic thrombocytopenic purpurain the Nordic countries: epidemiology andpredictors of chronic disease. Acta Paediatrica.2005; 94:178.

5. Provan D, Stasi R, Newland AC, Blanchette VS,Bolton-Maggs P, Bussel JB, et al. Internationalconsensus report on the investigation andmanagement of primary immunethrombocytopenia. Blood. 2010; 115:168.

6. Michel M, Lee K, Piette JC, Fromont P, Schaeffer A, Bierling P, et al. Platelet autoantibodies andlupus-associated thrombocytopenia. Br J Haematol. 2002; 119:354.

7. Kuwana M, Kaburaki J, Okazaki Y, Miyazaki H,Ikeda Y. Two types of autoantibody-mediated thrombocytopenia in patients with systemic lupuserythematosus. Rheumatology (Oxford). 2006; 45:851.

8. Zeller B, Rajantie J, Hedlund-Treutiger I,Tedgard U, Wesenberg F, Jonsson OG, et al.Childhood idiopathic thrombocytopenic purpurain the Nordic countries: epidemiology andpredictors of chronic disease. Acta Paediatr.2005; 94:178.

9. Kuhne T, Buchanan GR, Zimmerman S,Michaels LA, Kohan R, Berchtold W, et al. Aprospective comparative study of 2540 infantsand children with newly diagnosed idiopathicthrombocytopenic purpura (ITP) from theIntercontinental Childhood ITP Study Group. JPediatr. 2003; 143:605.

10. Rosthøj S, Hedlund-Treutiger I, Rajantie J, ZellerB, Jonsson OG, Elinder G, et al. Duration andmorbidity of newly diagnosed idiopathicthrombocytopenic purpura in children: Aprospective Nordic study of an unselected cohort.J Pediatr. 2003; 143:302.

11. Segal JB, Powe NR. Prevalence of immunethrombocytopenia: analyses of administrativedata. J Thromb Haemost. 2006; 4:2377.

12. Stasi R, Stipa E, Masi M, Cecconi M, Scimo MT,Oliva F, et al. Long-term observation of 208adults with chronic idiopathic thrombocytopenicpurpura. Am J Med. 1995; 98:436.

13. Portielje JE, Westendorp RG, Kluin-NelemansHC, Brand A. Morbidity and mortality in adultswith idiopathic thrombocytopenic purpura.Blood. 2001; 97:2549.

14. Neylon AJ, Saunders PW, Howard MR, ProctorSJ, Taylor PR. Clinically significant newlypresenting autoimmune thrombocytopenicpurpura in adults: a prospective study of apopulation-based cohort of 245 patients. Br JHaematol. 2003; 122:966.

15. Lacey JV, Penner JA. Management of idiopathicthrombocytopenic purpura in the adult. SeminThromb Hemost. 1977; 3:160.

16. George JN, Woolf SH, Raskob GE, Wasser JS,Aledort LM, Ballem PJ, et al. Idiopathicthrombocytopenic purpura: a practice guidelinedeveloped by explicit methods for the AmericanSociety of Hematology. Blood. 1996; 88:3.

17. Rodeghiero F, Stasi R, Gernsheimer T, MichelM, Provan D, Arnold DM, et al. Standardizationof terminology, definitions and outcome criteriain immune thrombocytopenic purpura of adultsand children: report from an internationalworking group. Blood. 2009; 113:2386.

18. Toltl LJ, Arnold DM. Pathophysiology and management of chronic immune thrombocytopenia: focusing on what matters. Br J Haematol. 2011;152:52.

19. Guidry JA, George JN, Vesely SK, KennisonSM, Terrell DR. Corticosteroid side-effects andrisk for bleeding in immune thrombocytopenicpurpura: patient and hematologist perspectives.Eur J Haematol. 2009; 83:175.

20. British Committee for Standards in HaematologyGeneral Haematology Task Force. Guidelines forthe investigation and management of idiopathicthrombocytopenic purpura in adults, children andin pregnancy. Br J Haematol. 2003; 120:574.

21. Provan D, Stasi R, Newland AC, Blanchette VS,Bolton-Maggs P, Bussel JB, et al. Internationalconsensus report on the investigation andmanagement of primary immunethrombocytopenia. Blood. 2010; 115:168.

22. Neunert C, Lim W, Crowther M, Cohen A,Solberg L Jr, Crowther MA. The AmericanSociety of Hematology 2011 evidence-basedpractice guideline for immune thrombocytopenia.Blood 2011; 117:4190.

23. George JN, Woolf SH, Raskob GE, Wasser JS,Aledort LM, Ballem PJ, et al. Idiopathicthrombocytopenic purpura: a practice guidelinedeveloped by explicit methods for the AmericanSociety of Hematology. Blood. 1996; 88:3.

24. Hujun. Donguibogam. Seoul; Bubinmunhwasa.2007:799.

25. Korean Medicine College Hepatology faculty.Hepato-internal medicine. Seoul: Dongyangmedical Publishing Company. 2013;616,620-21.

27. Choi MY, Lee SB, Kim SH, Kim YC, Lee JH,Woo HJ. A case report of ITP in a child patient.The Society of Korean Oriental InternalMedicine. 2007;200-206

28. Han CW, Kim CW, Lee JE, Rhy KR, Kim YC,Lee JH, et al. Therapeutic response of herbalmedicine in 8 adult patients with idiopathicthrombocytopenic purpura. The Society ofKorean Oriental Internal Medicine. 2004;82-94

29. Park SM, Seong HS, Han CW, Kim DW, KimYC, Lee JH, et al. A clinical report on 5 casesof ITP in adults administered herbal medicine.The Korean Society for Oriental InternalMedicine. 2002; 187-192.